Study Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA Subjects
Launched by WYETH IS NOW A WHOLLY OWNED SUBSIDIARY OF PFIZER · Jun 27, 2008
Trial Information
Current as of May 22, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Meet the 1987 ACR Revised Criteria for Rheumatoid Arthritis.
- • Documented evidence, confirmed by a blinded 3rd party assessor, of at least one erosion observed by X-ray at randomization based on X-ray taken at the screening visit.
- • Have received MTX as stable dose for 28 days prior to the screening visit.
- Exclusion Criteria:
- • Previous treatment with ETN, infliximab, adalimumab, other Tumor necrosis factor (TNF) -a inhibitors, anakinra or other biological agents.
- • Receipt of any DMARD, other than MTX, within 28 days before screening.
About Wyeth Is Now A Wholly Owned Subsidiary Of Pfizer
Wyeth, now a wholly owned subsidiary of Pfizer, is a global biopharmaceutical company dedicated to advancing healthcare through innovative research and development. With a strong legacy in the pharmaceutical industry, Wyeth focuses on discovering and delivering medicines that address significant medical needs across various therapeutic areas, including vaccines, biologics, and specialty pharmaceuticals. Leveraging Pfizer's extensive resources and expertise, Wyeth continues to drive scientific advancement and improve patient outcomes worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Valencia, , Spain
Warszawa, , Poland
Berlin, , Germany
Barcelona, , Spain
Krakow, , Poland
Paris, , France
Rouen, , France
Mainz, , Germany
Tours, , France
Montpellier, , France
Reggio Calabria, , Italy
Paris Cedex 13, , France
Frankfurt, , Germany
Amiens, , France
Ustron, , Poland
Budapest, , Hungary
Ostrava, , Czech Republic
Wirral, , United Kingdom
Koeln, , Germany
Izmir, , Turkey
Getafe, Madrid, Spain
Santander, Cantabria, Spain
Bilbao, Vizcaya, Spain
Miskolc, , Hungary
Homburg, , Germany
Wroclaw, , Poland
Prague, , Czech Republic
Amiens Cedex 1, , France
Echirolles, , France
Metz, , France
Paris Cedex 14, , France
Tours Cedex 9, , France
Hamburg Eilbeck, , Germany
Rijeka, , Hungary
Split, , Hungary
Zagreb, , Hungary
Jesi (Ancona), , Italy
Bytom, , Poland
Cambridge, Cambs, United Kingdom
Birmingham, West Midlands, United Kingdom
Aintree, , United Kingdom
Newcastle, , United Kingdom
Patients applied
Trial Officials
Pfizer CT.gov Call Center
Study Director
Wyeth is now a wholly owned subsidiary of Pfizer
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials